终末期肾病管理格局变化下的继发性甲状旁腺功能亢进甲状旁腺切除术
该回顾性研究分析195例因终末期肾病相关继发性甲状旁腺功能亢进接受甲状旁腺切除术的患者,比较有限、次全和全切除术的结局。结果显示次全切除术在肾移植可及性增加和透析方案改善的时代是最佳策略,但手术方式可能向更保守和个体化转变。
要点
- 次全甲状旁腺切除术是当前终末期肾病相关继发性甲旁亢的最佳手术策略。
- 有限切除术术后甲状旁腺激素水平更高,持续性疾病和复发更常见。
- 手术方式可能向更保守和患者个体化的方向转变。
核心结论
- 在肾移植可及性增加和透析方案改善的时代,次全甲状旁腺切除术是终末期肾病相关继发性甲状旁腺功能亢进的最佳策略。
- 手术方式可能向更保守和个体化的方法转变。
研究设计与样本
- 回顾性分析前瞻性收集的数据,共纳入195例患者。
- 患者分为三组:有限甲状旁腺切除术(切除<3个腺体,占13.8%)、次全切除术(切除3-3.5个腺体,占46.7%)和全切除术(切除4个腺体,占39.5%)。
主要发现
- 术前甲状旁腺激素水平(pg/mL)在有限、次全和全切除组分别为471(210-868)、1,087(627-1,795)和1,070(475-1,632)(P < .001)。
- 所有组术后甲状旁腺激素水平均下降,但有限切除组术后水平仍高于次全和全切除组(P < .001)。
- 所有组血清钙、磷和碱性磷酸酶水平均降至参考范围内。
- 有限切除组持续性疾病和复发更频繁(分别P = .02和P = .07)。
临床怎么用
- 对于终末期肾病相关继发性甲状旁腺功能亢进,次全甲状旁腺切除术可作为优先考虑的手术策略。
- 在肾移植可及性增加和透析方案改善的背景下,手术方式可向更保守和个体化方向调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The landscape of patients with end-stage renal disease is changing with the increasing availability of kidney transplantation. In the near future, a less aggressive approach to treat secondary hyperparathyroidism might be beneficial. We report outcomes of parathyroidectomy for end-stage renal disease-related hyperparathyroidism comparing the outcomes of limited, subtotal, and total parathyroidectomy. METHODS: We performed a retrospective analysis of prospectively collected data. Patients were divided into 3 parathyroidectomy subgroups: limited (<3 glands removed), subtotal (3-3.5 glands), and total (4 glands) parathyroidectomy. Primary outcome was serum levels of parathyroid hormone. Secondary endpoints were serum levels of calcium, phosphate, and alkaline phosphatase, postoperative complications, and persistent or recurrent disease rates. RESULTS: In total, 195 patients were included for analysis of whom 13.8% underwent limited parathyroidectomy, 46.7% subtotal parathyroidectomy, and 39.5% total parathyroidectomy. Preoperative parathyroid hormone levels (pg/mL) were 471 (210-868), 1,087 (627-1,795), and 1,070 (475-1,632) for the limited, subtotal, and total parathyroidectomy groups, respectively (P < .001). A decrease in serum parathyroid hormone was seen in all groups; however, postoperative levels remained greater in the limited parathyroidectomy group compared to the subtotal and total parathyroidectomy groups (P < .001). Serum calcium, phosphate, and alkaline phosphatase levels decreased in all groups to within the reference range. In the limited parathyroidectomy group, persistent disease and recurrence occurred more frequently (P = .02 and P = .07, respectively). CONCLUSION: Subtotal parathyroidectomy is the optimal strategy in an era with an increasing availability of kidney transplantation and improved regimens of dialysis. In this changing practice, the approach to parathyroid surgery, however, might shift to a less aggressive and patient-tailored approach.
引用
- van der Plas W, Kruijff S, Sidhu SB, et al. Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease. Surgery. 2020. PMID: 33059930. doi:10.1016/j.surg.2020.08.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。